ResearcherMeiwa HospitalActive in the last 2 years
Naoki Yamanaka
Matched on ORCID iD 0000-0002-6244-2686; OpenAlex author ID A5038177553. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 7)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 6
2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper
Papers 7
- Predicting Pathological Response to Preoperative Chemotherapy in Pancreatic Ductal Adenocarcinoma Using Post-Chemotherapy Computed Tomography Radiomics. Last author DOI 10.7759/cureus.52193↗
- A Liver-First Approach Using Ablation for Oligometastatic Pancreatic Cancer: A Report of a Successful Case. Last author DOI 10.7759/cureus.46671↗
- Impact of the aberrant right hepatic artery on local recurrence of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy. Last author DOI 10.1016/j.surg.2022.02.010↗
- Preoperative C-reactive protein to albumin ratio is a predictor of survival after pancreatic resection for pancreatic ductal adenocarcinoma. Last author DOI 10.1111/ajco.13123↗
- A combination of platelet-to-lymphocyte ratio and carbohydrate antigen 19-9 predict early recurrence after resection of pancreatic ductal adenocarcinoma. Last author DOI 10.21037/atm.2019.08.35↗
- The preoperative modified Glasgow prognostic score for the prediction of survival after pancreatic cancer resection following non-surgical treatment of an init… Last author DOI 10.5114/wo.2018.81344↗
- Combination Chemotherapy with Itraconazole for Treating Metastatic Pancreatic Cancer in the Second-line or Additional Setting. Last author PMID 26124377↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shinichi Ikuta · 7 shared papers, 2015–2024 · strength 1.17
- Paper Predicting Pathological Response to Preoperative Chemotherapy in Pancreatic Ductal Adenocarcinoma Using Post-Chemothera… DOI 10.7759/cureus.52193↗
- Paper A Liver-First Approach Using Ablation for Oligometastatic Pancreatic Cancer: A Report of a Successful Case. DOI 10.7759/cureus.46671↗
- Paper Preoperative C-reactive protein to albumin ratio is a predictor of survival after pancreatic resection for pancreatic d… DOI 10.1111/ajco.13123↗
- Takayoshi Nakajima · 4 shared papers, 2018–2024 · strength 0.81
- Paper Predicting Pathological Response to Preoperative Chemotherapy in Pancreatic Ductal Adenocarcinoma Using Post-Chemothera… DOI 10.7759/cureus.52193↗
- Paper A Liver-First Approach Using Ablation for Oligometastatic Pancreatic Cancer: A Report of a Successful Case. DOI 10.7759/cureus.46671↗
- Paper Impact of the aberrant right hepatic artery on local recurrence of pancreatic ductal adenocarcinoma after pancreaticodu… DOI 10.1016/j.surg.2022.02.010↗
- Takashi Sonoda · 3 shared papers, 2015–2019 · strength 0.30
- Paper A combination of platelet-to-lymphocyte ratio and carbohydrate antigen 19-9 predict early recurrence after resection of… DOI 10.21037/atm.2019.08.35↗
- Paper The preoperative modified Glasgow prognostic score for the prediction of survival after pancreatic cancer resection fol… DOI 10.5114/wo.2018.81344↗
- Paper Combination Chemotherapy with Itraconazole for Treating Metastatic Pancreatic Cancer in the Second-line or Additional S… PMID 26124377↗
- Hideaki Iwama · 1 shared paper, 2022 · strength 0.16
- Etsuro Hatano · 1 shared paper, 2022 · strength 0.16
- Hiroshi Tsubamoto · 1 shared paper, 2015 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.